Study of fatty liver and nutrition in rural Bangladesh
Part of Hormones & metabolism clinical trials.
This study looks at metabolic fatty liver disease (MAFLD) in adults living in a rural area of Bangladesh. It aims to understand how diet and metabolic risk factors like blood sugar or cholesterol relate to the condition, which may help in finding better ways to prevent or manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You live in a rural community in Bangladesh that is part of this study
- You are not pregnant
- You do not have a severe illness that makes it hard to take part, such as being bedridden, having paralysis, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
This study tests a nutrition program for pregnant women, adolescent girls, and young children living in Dhaka slums. It is designed to support healthier nutrition during a key growth or pregnancy period.
This study looks at how a specific gut bacteria (Ruminococcus gnavus) and its byproducts are linked to fatty liver disease (MAFLD). It compares people with the condition to healthy individuals to better understand the connection.
This study looks at how common obesity is in people with a type of fatty liver disease called MASLD. If you have fatty liver and are overweight, this trial may help doctors understand the link between the two conditions.
This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.
This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.